Adjunct Faculty
Adjunct Faculty are scientists or others who are employed outside of the school but have a specific, mutually beneficial role to Yale School of Medicine department programs.
Adjunct rank detailsEarl Glusac, MD
Professor AdjunctDownloadHi-Res Photo
About
Copy Link
Titles
Professor Adjunct
Director, Physician Associate Studies
Biography
Dr. Glusac’s interests focus on the study of benign lesions that mimic malignant melanoma, a current topic of great interest in the field and the subject of many invited lectures, publications and editorials by Dr. Glusac. He has served the American Boards of Pathology and Dermatology and the editorial boards of the Journal of Cutaneous Pathology and the American Journal of Dermatopathology. He is past president of the American Society of Dermatopathology, and he is an author for the World Health Organization’s Classification of Tumours of the Skin.
Last Updated on January 14, 2024.
Appointments
Pathology
Professor AdjunctPrimary
Other Departments & Organizations
Education & Training
- Fellow
- Stanford University Medical Center, Palo Alto, CA (1994)
- Chief Resident
- Cedars-Sinai Medical Center, Los Angeles, CA (1993)
- Resident
- Cedars-Sinai Medical Center, Los Angeles, CA (1992)
- Rotating Intern
- Wayne State University Medical Center, Detroit, MI (1988)
- MD
- Michigan State University (1987)
Research
Copy Link
Overview
Medical Research Interests
Carcinoma, Squamous Cell; Dermatology; Lymphoma; Medical Oncology; Melanoma
Research at a Glance
Yale Co-Authors
Frequent collaborators of Earl Glusac's published research.
Publications Timeline
A big-picture view of Earl Glusac's research output by year.
Research Interests
Research topics Earl Glusac is interested in exploring.
Jennifer Madison McNiff, MD
Jean Bolognia, MD
David J Leffell, MDCM
Robert Tigelaar, MD
Christine Ko, MD
Irwin Braverman, MD
42Publications
2,044Citations
Melanoma
Carcinoma, Squamous Cell
Publications
2023
PRAME‐negativity in sclerosing nevi with pseudomelanomatous features supports classification as an indolent lesion
Tang H, McNiff J, Glusac E, Ko C. PRAME‐negativity in sclerosing nevi with pseudomelanomatous features supports classification as an indolent lesion. Journal Of Cutaneous Pathology 2023, 50: 1001-1005. PMID: 37565491, DOI: 10.1111/cup.14505.Peer-Reviewed Original ResearchAltmetricConceptsCognitive bias in pathology, as exemplified in dermatopathology
Ko C, Glusac E. Cognitive bias in pathology, as exemplified in dermatopathology. Human Pathology 2023, 140: 267-275. PMID: 36906184, DOI: 10.1016/j.humpath.2023.03.003.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and Concepts
2022
Acute Epstein–Barr virus infection resembling cutaneous T‐cell lymphoma
Fan R, Baker C, Glusac E, Xu M, Gru A, Cohen J. Acute Epstein–Barr virus infection resembling cutaneous T‐cell lymphoma. Journal Of Cutaneous Pathology 2022, 50: 238-242. PMID: 36349388, DOI: 10.1111/cup.14357.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsAcute Epstein-Barr virus infectionEpstein-Barr virus infectionCutaneous T-cell lymphomaT-cell lymphomaEBV infectionVirus infectionAcute EBV infectionChronic EBV infectionInfectious mononucleosisCutaneous eruptionCutaneous manifestationsErythema multiformeViral exanthemsLymphoproliferative disordersHistopathologic featuresPrimary infectionInfectionLymphomaDisordersMononucleosisExanthemMultiforme
2020
Melanoma in situ: Don't make the cure worse than the disease
Prassinos A, Glusac E, Leffell DJ. Melanoma in situ: Don't make the cure worse than the disease. Journal Of The American Academy Of Dermatology 2020, 85: 520. PMID: 32387662, DOI: 10.1016/j.jaad.2020.04.168.Peer-Reviewed Original ResearchCitationsAltmetric
2008
Fatal Subcutaneous Panniculitis‐Like T‐Cell Lymphoma (Sptcl) with Interface Change and Dermal Mucin, A Dead‐Ringer for Lupus Erythematosus
Ma L, Bandarchi B, Glusac E. Fatal Subcutaneous Panniculitis‐Like T‐Cell Lymphoma (Sptcl) with Interface Change and Dermal Mucin, A Dead‐Ringer for Lupus Erythematosus. Journal Of Cutaneous Pathology 2008, 32: 101-102. DOI: 10.1111/j.0303-6987.2005.320eh.x.Peer-Reviewed Original ResearchConceptsSubcutaneous panniculitis-like T-cell lymphomaPanniculitis-like T-cell lymphomaT-cell lymphomaLupus erythematosusLymphoid infiltratesFatal hemophagocytic syndromeInterstitial lymphoid infiltratePulmonary lymphoid infiltratesSimilar immunohistochemical profileVacuolar interface changesDense lymphocytic infiltrateDermal mucin depositionT-cell receptor gamma geneReceptor gamma geneHemophagocytic syndromeLung biopsyLymph nodesLymphocytic infiltrateMucin depositionSystemic involvementDermal mucinUlcerated plaquesMonoclonal rearrangementImmunohistochemical profileSkin biopsies
2007
Cutaneous Lymphomas
Subtil A, Glusac E. Cutaneous Lymphomas. Basic And Clinical Dermatology 2007, 401-412. DOI: 10.3109/9781420005455.027.Peer-Reviewed Original Research
2006
Reply
McNiff J, Subtil A, Cowper S, Lazova R, Glusac E. Reply. Journal Of Cutaneous Pathology 2006, 33: 764-764. DOI: 10.1111/j.1600-0560.2006.00547.x.Commentaries, Editorials and LettersCitations
2004
Primary Cutaneous B-Cell Lymphoma Treated With Radiotherapy: A Comparison of the European Organization for Research and Treatment of Cancer and the WHO Classification Systems
Smith BD, Glusac EJ, McNiff JM, Smith GL, Heald PW, Cooper DL, Wilson LD. Primary Cutaneous B-Cell Lymphoma Treated With Radiotherapy: A Comparison of the European Organization for Research and Treatment of Cancer and the WHO Classification Systems. Journal Of Clinical Oncology 2004, 22: 634-639. PMID: 14966086, DOI: 10.1200/jco.2004.08.044.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsCutaneous B-cell lymphomaPrimary cutaneous B-cell lymphomaLarge B-cellInitial biopsy specimensB-cell lymphomaFollicle center cellsB cellsOverall survivalBiopsy specimensFive-year relapse-free survivalEuropean OrganizationFive-year overall survivalCenter cellsRelapse-free survivalWHO classification systemExtracutaneous diseaseLocal radiotherapyIndolent coursePrimary outcomeInitial treatmentTreatment of cancerHistopathologic subtypePathologic classificationNoncutaneous sitesDLB
2003
Palpable Purpura in an Asthmatic Woman With Eosinophilia—Quiz Case
Pol-Rodriguez M, Crane S, Feinberg D, Glusac E, Bolognia J. Palpable Purpura in an Asthmatic Woman With Eosinophilia—Quiz Case. JAMA Dermatology 2003, 139: 803-808. PMID: 12810518, DOI: 10.1001/archderm.139.6.803-a.Peer-Reviewed Case Reports and Technical NotesCitations
2002
Differential Diagnosis in Dermatopathology II, 2nd Edition.
Glusac E. Differential Diagnosis in Dermatopathology II, 2nd Edition. American Journal Of Dermatopathology 2002, 24: 380. DOI: 10.1097/00000372-200208000-00023.Peer-Reviewed Original Research
News
Copy Link
News
- May 21, 2025
Several Pathology Faculty Recognized as ‘Top Doctors’ by Connecticut Magazine
- May 01, 2024
Yale Pathology Faculty Members Recognized as Top Doctors
- February 13, 2024Source: National Geographic
Melanoma is overdiagnosed at ‘alarming’ rates. Here’s what to know.
- May 01, 2023
Connecticut Magazine’s 2023 “Top Doctors” issue recognizes 81 Smilow Cancer Hospital and Yale Cancer Center physicians
Get In Touch
Copy Link
Contacts
Email